Cite
Handgrip strength is a comorbidity marker in systemic necrotizing vasculitides and predicts the risk of fracture and serious adverse events.
MLA
Henriquez, Soledad, et al. “Handgrip Strength Is a Comorbidity Marker in Systemic Necrotizing Vasculitides and Predicts the Risk of Fracture and Serious Adverse Events.” Rheumatology (Oxford, England), vol. 59, no. 9, Sept. 2020, pp. 2581–90. EBSCOhost, https://doi.org/10.1093/rheumatology/kez680.
APA
Henriquez, S., Dunogué, B., Porcher, R., Régent, A., Cohen, P., Berezne, A., Kolta, S., Le Jeunne, C., Mouthon, L., Roux, C., Guillevin, L., Briot, K., & Terrier, B. (2020). Handgrip strength is a comorbidity marker in systemic necrotizing vasculitides and predicts the risk of fracture and serious adverse events. Rheumatology (Oxford, England), 59(9), 2581–2590. https://doi.org/10.1093/rheumatology/kez680
Chicago
Henriquez, Soledad, Bertrand Dunogué, Raphael Porcher, Alexis Régent, Pascal Cohen, Alice Berezne, Sami Kolta, et al. 2020. “Handgrip Strength Is a Comorbidity Marker in Systemic Necrotizing Vasculitides and Predicts the Risk of Fracture and Serious Adverse Events.” Rheumatology (Oxford, England) 59 (9): 2581–90. doi:10.1093/rheumatology/kez680.